Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Champions Oncology, Inc. (CSBR)

7.86
-0.06
(-0.76%)
At close: April 22 at 4:00:01 PM EDT
7.86
0.00
(0.00%)
Pre-Market: 7:58:12 AM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Ronnie Morris M.D. CEO & Director 400k -- 1966
Mr. David Barry Miller M.B.A. Chief Financial Officer 260k -- 1969
Dr. Maria Mancini Ph.D. Chief Operating Officer -- -- --
Mr. Arthur Hanson Vice President of Technology -- -- --
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS Vice President of Global Marketing -- -- --
Dr. Michael Ritchie M.B.A., Ph.D. Chief Commercial Officer -- -- --
Dr. Karin Abarca Heidemann Ph.D. Executive Vice President of Global Scientific Operations -- -- --
Dr. Marianna Zipeto Ph.D. Executive Vice President of Commercial, Research Services & Partnering -- -- --

Champions Oncology, Inc.

One University Plaza
Suite 307
Hackensack, NJ 07601
United States
201 808 8400 https://www.championsoncology.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
210

Description

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Corporate Governance

Champions Oncology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 16, 2025 at 10:59 AM UTC - July 21, 2025 at 12:00 PM UTC

Champions Oncology, Inc. Earnings Date

Recent Events

March 17, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

March 11, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 3, 2025 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

December 16, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

December 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 30, 2024 at 12:00 AM UTC

S-8: Offering Registrations

October 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers